Cargando…
Organoids to model liver disease
The organoid model represents a major breakthrough in cell biology that has revolutionised biomedical research. Organoids are 3D physiological in vitro structures that recapitulate morphological and functional features of in vivo tissues and offer significant advantages over traditional cell culture...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672322/ https://www.ncbi.nlm.nih.gov/pubmed/33241206 http://dx.doi.org/10.1016/j.jhepr.2020.100198 |
_version_ | 1783611108733485056 |
---|---|
author | Nuciforo, Sandro Heim, Markus H. |
author_facet | Nuciforo, Sandro Heim, Markus H. |
author_sort | Nuciforo, Sandro |
collection | PubMed |
description | The organoid model represents a major breakthrough in cell biology that has revolutionised biomedical research. Organoids are 3D physiological in vitro structures that recapitulate morphological and functional features of in vivo tissues and offer significant advantages over traditional cell culture methods. Liver organoids are of particular interest because of the pleiotropy of functions exerted by the human liver, their utility to model different liver diseases, and their potential application as cell-based therapies in regenerative medicine. Moreover, because they can be derived from patient tissues, organoid models offer new perspectives in personalised medicine and drug discovery. In this review, we discuss the current liver organoid models for the study of liver disease. |
format | Online Article Text |
id | pubmed-7672322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-76723222020-11-24 Organoids to model liver disease Nuciforo, Sandro Heim, Markus H. JHEP Rep Review The organoid model represents a major breakthrough in cell biology that has revolutionised biomedical research. Organoids are 3D physiological in vitro structures that recapitulate morphological and functional features of in vivo tissues and offer significant advantages over traditional cell culture methods. Liver organoids are of particular interest because of the pleiotropy of functions exerted by the human liver, their utility to model different liver diseases, and their potential application as cell-based therapies in regenerative medicine. Moreover, because they can be derived from patient tissues, organoid models offer new perspectives in personalised medicine and drug discovery. In this review, we discuss the current liver organoid models for the study of liver disease. Elsevier 2020-10-22 /pmc/articles/PMC7672322/ /pubmed/33241206 http://dx.doi.org/10.1016/j.jhepr.2020.100198 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Nuciforo, Sandro Heim, Markus H. Organoids to model liver disease |
title | Organoids to model liver disease |
title_full | Organoids to model liver disease |
title_fullStr | Organoids to model liver disease |
title_full_unstemmed | Organoids to model liver disease |
title_short | Organoids to model liver disease |
title_sort | organoids to model liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672322/ https://www.ncbi.nlm.nih.gov/pubmed/33241206 http://dx.doi.org/10.1016/j.jhepr.2020.100198 |
work_keys_str_mv | AT nuciforosandro organoidstomodelliverdisease AT heimmarkush organoidstomodelliverdisease |